Hong Kong is advancing to become an innovative life and healthcare hub in the region. Market opportunities are driven by:
- hospital redevelopment projects
- demand for intelligent healthcare technologies to support an ageing population
- the need for effective prevention, screening, diagnostic, and treatment solutions for high-incidence and chronic diseases
Canadian companies with market-ready or near-commercialized medical devices, digital health solutions, and therapeutics can use Hong Kong as a first reference market in Asia. You can engage through hospital pilot projects, private healthcare buyers, distributors, and strategic partners. You can also pursue clinical collaborations that support product validation and commercialization.
By participating in Hong Kong International Health Week, you’ll access:
- tailored pre-market briefing
- market intelligence and strategic insights
- curated B2B meetings and visibility at the Canada Pavilion
- pitching opportunities at industry forums at HKIMHF or ASGH
- conferences and networking opportunities at HKIMHF and ASGH
- site visits to leading healthcare and innovation institutions
Participation is free (travel and accommodation not included).
Optional: Companies may purchase their own exhibition booth directly from HKTDC.
- HKIMHF Exhibition deadline: March 6, 2026
- ASGH InnoHealth Showcase deadline: March 28, 2026